Atossa Therapeutics, Inc.ATOSNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-27.60M
↓ 56% below average
Average (9y)
$-17.67M
Historical baseline
Range
High:$-6.07M
Low:$-31.35M
CAGR
+9.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-27.60M | +12.0% |
| 2023 | $-31.35M | -13.3% |
| 2022 | $-27.68M | -35.1% |
| 2021 | $-20.50M | -40.8% |
| 2020 | $-14.56M | +15.4% |
| 2019 | $-17.21M | -51.1% |
| 2018 | $-11.39M | -46.0% |
| 2017 | $-7.80M | -28.6% |
| 2016 | $-6.07M | +51.4% |
| 2015 | $-12.49M | - |